DiaVision
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
DiaVision - overview
Established
2021
Location
Seoul, -, South Korea
Primary Industry
Healthcare IT
About
Founded in 2021 and based in Seoul, South Korea, DiaVision operates as a developer of a healthcare solution that uses Artificial Intelligence to detect and prevent various diseases through its point-of-care testing process. The firm’s business cooperation partners include Samsung, AccessBio, BioFront, Maeil Health Nutrition, Korea University Guro Hospital, etc. In December 2023, DiaVision raised KRW 500 million in seed funding from investor Korea Tech Incubator for Startup, being selected for Accelerator Investment-Driven Tech Incubator Program. The firm provides individualized management solutions that predict and analyze various diseases using rapid diaognostic tests to help prevent diseases.
The company uses home tests and on-site diagnostic data to offer digital healthcare solutions using biometric data in real time. The company intends to use the December 2023 funding to expand its research and development facilities, strengthen its R&D capabilities, and recruit key personnel.
Current Investors
Korea Tech Incubator for Startup, Lotte Ventures, BlissVine Ventures
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Analytics & Performance Software, Medical Software
Website
www.diavision.co.kr
Verticals
Artificial Intelligence, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.